Effects of AZD1775 on the PK Substrates for CYP3A, CYP2C19, CYP1A2 and on QT Interval in Patients With Advanced Cancer
Clinical trial NCT03333824 · COMPLETED
Trial details
- NCT number
- NCT03333824
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-01
- Primary completion
- 2019-01-22
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.